Discover seven lung cancer companies advancing promising candidates through the clinic, from viral immunotherapies to ...

The European Union has launched the Choose Europe for Science initiative and pledged €500 million in funding to attract US ...

Small-molecule drugs have been a mainstay of the pharmaceutical industry for nearly a century and they continue to play a crucial role in the industry’s therapeutic arsenal. Advances in technology and ...

Find out the best way to find the right CDMO for your biotech. Experts shared some advice to help companies through the ...

Discover 9 promising small molecule drug discovery companies that recently raised funding for their potentially breakthrough ...

Biopharmas have been scaling back on AAV research for sometime now. Find out why and what's on the horizon for drug delivery ...

Learn how to optimize cold chain logistics for biotherapeutics in EMEA and overcome key challenges in delivery and regulation ...

Learn about April 2025’s top biotech deals, featuring major collaborations in bispecific antibodies, protein therapies, and ...

Let us delve into some of the TLR agonists in the clinic and why the careful selection of these drugs is crucial.

What are the causes of Parkinson’s disease and current therapeutic approaches? Although the underlying cause of Parkinson’s is unknown, scientists do know that the disease results from a loss of ...